{"database": "lobbying", "table": "lobbying_activities", "rows": [[1987936, "26d88045-a41a-42d0-b6b2-801894062fdf", "Q2", "HOLLAND & KNIGHT LLP", 18466, "THE BIOSIMILARS FORUM", 2017, "second_quarter", "MED", "Medicare reimbursement issues, FDA regulation of biosimilars;  S. 934, H.R. 2430, the FDA Reauthorization Act of 2017.", "Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", 120000, null, 0, 0, "2017-07-14T15:53:47.137000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1987936"], "units": {}, "query_ms": 0.3557860618457198, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}